Amidst the 27th annual meeting of the Latin American Society of Interventional Cardiology and the annual meeting of the Mexican Society of Interventional Cardiology, the 12th edition of our course for fellow interventionists ProEducar was held. The course – directed by Dr. Leandro Lasave (ARG) and codirected by Drs. Gabriel Maluenda (CHL), Guering Eid Lidt...
The GLOBAL SYMPLICITY Registry is the largest study, with the longest followup, of real-world patients (real world data) presenting high blood pressure, treated with renal denervation. Time in Target Range (TTR), estimates the time a patient needs to control their blood pressure, and is an independent predictor of cardiovascular events. The aim of this registry,...
Fractional flow reserve (FFR) has been shown effective and safe by different studies, yet not at 5 years. The aim of this multicenter registry was to assess the impact of thrombotic risk (as per CREDO-Kyoto score) as a predictor of cardiovascular events at 5 years in patients with deferred revascularization after FFR measurement. The score...
SOLACI and the Latin American Interventional Women Group (Grupo MIL) continue to promote continuing medical education, in this case with four simultaneous activities organized with Medtronic and aimed at female interventional specialists. In this one-of-a-kind session, participants will have the opportunity to discuss clinical data and procedural techniques with experts. The event will be held on...
The 2021 Handbook of Hemodynamic and Interventional Cardiology Procedures, driven by the SOLACI Chapter of Nurses, Technicians, and Medical Technologists, is already out. This important work compiles all advancements in interventional cardiology to date, including technological developments, new treatment techniques, and novelties in several thematic areas. In this regard, the handbook includes chapters on updates...
01- ISCHEMIA: Prognosis is Determined by Anatomy, not Functionality The ISCHEMIA study keeps providing scientific news. This work in patients with stable coronary artery disease had already shown (to our surprise) that ischemic burden does not predict 4-year mortality. Read also HERE 02- Chile Sessions 2021 | Clinical Case Contest for Young Interventionists It is with great...
Adding new medication in moderate doses to control hypertension conveniently maximizes efficacy, reduces adverse effects and minimizes costs, among other advantages. On the flipside, patients having to remember a whole list of drugs and their combination will often lead to non-adherence or forgetfulness. The latter has been shown not only by dedicated trials, but also...
During the virtual SOLACI-CACI 2021 Congress, the 11th ProEducar Fellows Course—SOLACI’s traditional activity aimed at expanding knowledge and providing didactic tools for all interventional trainees in Latin America—was held. The course was a huge success: almost 1500 people accessed the Andreas Gruentzig Virtual Room where the activity took place. Furthermore, over 35 prestigious speakers from all...
✔️ MEDTRONIC Symposium in the SOLACI-CACI 2021 Virtual Congress.✔️ Topic: Current Controversies in Interventional Cardiology. 👨🏫 Program: Opening – Dr. Aníbal Damonte. Controversy in Bifurcation Lesions: Which Strategy is Adequate When Implanting Two Stents Is Possible? DK Crush as an Option – Dr. Carlos Uribe. Provisional Stenting as an Option – Dr. Ricardo Costa...
Patients under evaluation for acute coronary syndrome (ACS) without clear ischemia signs in an electrocardiogram find no benefit in a 0/1-hour high-sensitivity troponin T (ultra-fast) protocol compared with the conventional 0/3-hour protocol. These data come from the RAPID-TnT trial presented during the scientific sessions at the American College of Cardiology (ACC) 2021 Congress, simultaneously published in...